Cointime

AAVogen

company

About

AAVogen is a biotech startup that develops gene therapeutics for muscle wasting diseases.

  • 1 - 10

Highlights

Total Funding Amount
$250K
Funding Rounds
2
Investors
2

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$25K
Industries
Biotechnology,Health Care
Founded date
Aug 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

AAVogen is a biotech startup that develops gene therapeutics for muscle wasting diseases. This includes muscular dystrophy, inflammatory myopathies and cancer cachexia. We make you stronger.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$250K
AAVogen has raised a total of $250K in funding over 2 rounds. Their latest funding was raised on Sep 1, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 1, 2019 Grant $225K 1 — — Detail
Aug 15, 2015 Pre-seed $25K 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
AAVogen is funded by 2 investors. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and Kilpatrick Townsend are the most recent investors.
Investor Name Lead Investor Funding Round
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) — Grant
Kilpatrick Townsend — Pre-seed
Cointime
เนื้อหา
บริษัท